JRUD:F:F-JPMorgan ETFs (Ireland) ICAV - US Research Enhanced Index Equity UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 44.64

Change

+0.75 (+1.71)%

Market Cap

USD 0.45B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.21 (-0.77%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.56 (-1.08%)

USD 115.04B
FRCJ:F UBS MSCI Japan Socially Respon..

-0.21 (-0.97%)

USD 83.57B
SXR8:F iShares Core S&P 500 UCITS ETF..

+4.46 (+0.89%)

USD 80.45B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.36 (-0.65%)

USD 76.57B
EUNL:F iShares Core MSCI World UCITS ..

+0.38 (+0.42%)

USD 72.04B
SXRZ:F iShares VII PLC - iShares Nikk..

-0.85 (-0.36%)

USD 58.19B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.11 (-0.69%)

USD 56.18B
VUSA:F Vanguard Funds Public Limited ..

+0.46 (+0.50%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.73 (+0.81%)

USD 49.95B

ETFs Containing JRUD:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.88% 84% B 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.88% 82% B 68% D+
Trailing 12 Months  
Capital Gain 37.50% 91% A- 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 37.50% 90% A- 78% C+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 5.38% 66% D+ 66% D+
Dividend Return 5.38% 65% D 61% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.37% 54% F 78% C+
Risk Adjusted Return 47.33% 73% C 76% C+
Market Capitalization 0.45B 59% D- 49% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike